Alexion Pharmaceuticals investor relations material

Listen to the latest call from Alexion Pharmaceuticals

Alexion Pharmaceuticals, Inc. is a biopharmaceutical company specializing in the development and commercialization of innovative therapies for patients with rare and severe disorders. Alexion’s core business is focused on serving individuals afflicted with ultra-rare disorders through commercializing high-quality products that are priced based on their value. Alexion Pharmaceuticals is a subsidiary of AstraZeneca, and an American pharmaceutical company headquartered in Boston, Massachusetts

  • Ticker

  • Country


Dig deeper into the Alexion Pharmaceuticals fundamentals on Quartr.